RenovoRx, Inc. (RNXT)

RenovoRx Statistics

Total Valuation

RenovoRx has a market cap or net worth of $36.59 million. The enterprise value is $24.02 million.

Market Cap	36.59M
Enterprise Value	24.02M

Important Dates

The last earnings date was Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

RenovoRx has 45.05 million shares outstanding. The number of shares has increased by 40.21% in one year.

Current Share Class	45.05M
Shares Outstanding	45.05M
Shares Change (YoY)	+40.21%
Shares Change (QoQ)	+3.75%
Owned by Insiders (%)	3.30%
Owned by Institutions (%)	10.80%
Float	39.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.38
Forward PS	10.96
PB Ratio	3.22
P/TBV Ratio	3.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	16.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.15, with a Debt / Equity ratio of 0.01.

Current Ratio	7.15
Quick Ratio	6.58
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -100.47% and return on invested capital (ROIC) is -62.39%.

Return on Equity (ROE)	-100.47%
Return on Assets (ROA)	-51.58%
Return on Invested Capital (ROIC)	-62.39%
Return on Capital Employed (ROCE)	-102.70%
Weighted Average Cost of Capital (WACC)	9.71%
Revenue Per Employee	$87,588
Profits Per Employee	-$721,706
Employee Count	17
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.10% in the last 52 weeks. The beta is 1.00, so RenovoRx's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-35.10%
50-Day Moving Average	0.94
200-Day Moving Average	1.00
Relative Strength Index (RSI)	37.91
Average Volume (20 Days)	281,673

Short Selling Information

The latest short interest is 505,892, so 1.12% of the outstanding shares have been sold short.

Short Interest	505,892
Short Previous Month	470,946
Short % of Shares Out	1.12%
Short % of Float	1.27%
Short Ratio (days to cover)	1.57

Income Statement

In the last 12 months, RenovoRx had revenue of $1.49 million and -$12.27 million in losses. Loss per share was -$0.33.

Revenue	1.49M
Gross Profit	1.17M
Operating Income	-12.37M
Pretax Income	-12.27M
Net Income	-12.27M
EBITDA	-12.37M
EBIT	-12.37M
Loss Per Share	-$0.33

Balance Sheet

The company has $12.36 million in cash and $78,000 in debt, with a net cash position of $12.28 million or $0.27 per share.

Cash & Cash Equivalents	12.36M
Total Debt	78,000
Net Cash	12.28M
Net Cash Per Share	$0.27
Equity (Book Value)	11.27M
Book Value Per Share	0.25
Working Capital	11.80M

Cash Flow

Operating Cash Flow	-11.30M
Capital Expenditures	n/a
Depreciation & Amortization	2,000
Net Borrowing	n/a
Free Cash Flow	-11.30M
FCF Per Share	-$0.25

Margins

Gross Margin	78.71%
Operating Margin	-830.69%
Pretax Margin	-823.98%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RenovoRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-40.21%
Shareholder Yield	-40.21%
Earnings Yield	-33.79%
FCF Yield	-31.13%

Analyst Forecast

The average price target for RenovoRx is $6.91, which is 750.88% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.91
Price Target Difference	750.88%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	77.61%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3